menu
    • menu

    Company profile for Istari Oncology

    NEW Drugs in Dev: 4
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    It is a clinical-stage biotechnology company focused on developing innovative immuno-oncology platforms for the treatment of solid tumors, including glioblastoma and melanoma. The company was founded as a result of the research contributions of Darell Bigner, MD, PhD and Matthias Gromeier, MD at Duke University in Durham, North Carolina. Both are leaders in their respective research fields of virology, immunology, monoclonal d...
    It is a clinical-stage biotechnology company focused on developing innovative immuno-oncology platforms for the treatment of solid tumors, including glioblastoma and melanoma. The company was founded as a result of the research contributions of Darell Bigner, MD, PhD and Matthias Gromeier, MD at Duke University in Durham, North Carolina. Both are leaders in their respective research fields of virology, immunology, monoclonal development, and clinical medicine, particularly in the treatment of brain tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Istari OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    430 Davis Dr Suite 560 Morrisville, NC 27560
    Telephone
    Telephone
    919.245.7662
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.istarioncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/istari-oncology/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Istari Announces First Patient Dosed in NMIBC Substudy of LUMINOS-103 Trial
    Istari Announces First Patient Dosed in NMIBC Substudy of LUMINOS-103 Trial

    31 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230131005229/en

    BUSINESSWIRE
    31 Jan 2023
    Share Share
    Istari Oncology Announces Presentation of Clinical Responses from LUMINOS- 102
    Istari Oncology Announces Presentation of Clinical Responses from LUMINOS- 102

    18 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221018005164/en

    BUSINESSWIRE
    18 Oct 2022
    Share Share
    Istari Oncology Presents Positive Data from Ph1 Study of PVSRIPO in Patients
    Istari Oncology Presents Positive Data from Ph1 Study of PVSRIPO in Patients

    09 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201109005176/en/Istari-Oncology-Presents-Positive-Data-from-Phase-1-Study-of-PVSRIPO-in-Patients-with-Unresectable-Treatment-Refractory-Melanoma-at-The-Society-for-Immunotherapy-of-Cancer-SITC-35th-Anniversary-Annual-Meeting

    BUSINESSWIRE
    09 Nov 2021
    Share Share
    Istari Oncology Presents Data on Its PVSRIPO Immunotherapy at SITC & SNO
    Istari Oncology Presents Data on Its PVSRIPO Immunotherapy at SITC & SNO

    09 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211109005964/en

    BUSINESSWIRE
    09 Nov 2021
    Share Share
    First Patient Dosed With PVSRIPO in Istari Oncology’s LUMINOS-103
    First Patient Dosed With PVSRIPO in Istari Oncology’s LUMINOS-103

    12 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211012005382/en/First-Patient-Dosed-With-PVSRIPO-in-Istari-Oncology%E2%80%99s-LUMINOS-103-Phase-12-Bladder-Cancer-Sub-Study

    BUSINESSWIRE
    12 Oct 2021
    Share Share
    Dosing begins in PVSRIPO in Istari Oncology’s LUMINOS-103 Phase 1/2 Trial
    Dosing begins in PVSRIPO in Istari Oncology’s LUMINOS-103 Phase 1/2 Trial

    12 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211012005382/en

    BUSINESSWIRE
    12 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search